The gastrointestinal program features focused discussions on key developments in colorectal, pancreatic, and other GI cancers. Below, explore session highlights and meet the faculty leading conversations that translate new data into practical approaches for care.

Agenda Highlights

March 14, 10:25 AM
Optimizing Immunotherapy Sequencing in Gastroesophageal Malignancies: Neoadjuvant Chemo–IO vs Perioperative Chemo/RT Followed by Adjuvant Anti–PD-1
March 14, 2:10 PM
Is There a Role for Adjuvant HAI Following Liver Resection vs Adjuvant Chemotherapy?: Yes vs No
March 15, 10:25 AM
IO Rechallenge in Esophageal and Gastric Cancers: Balancing Safety Concerns vs Potential Benefit of Reinitiation
Back to top